Skip to main content

Advertisement

Log in

Nutritional Support with Endoluminal Stenting During Neoadjuvant Therapy for Esophageal Malignancy

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Perioperative nutrition remains a significant problem in patients undergoing neoadjuvant treatment for esophageal cancer. The aim of this study was to evaluate the effectiveness of esophageal stenting, feeding tube placement, or observation among esophageal cancer patients receiving neoadjuvant therapy.

Methods and Materials

A review of our prospectively maintained database of esophageal cancer patients identified 58 patients who underwent neoadjuvant chemoradiotherapy. Operative complications, tolerance of neoadjuvant therapy, and nutritional outcomes were evaluated according to the type of nutritional adjunct used.

Results

A total of 25 patients received esophageal stenting with self-expanding silicone stents. Of these, 19 patients had feeding tubes placed (without stenting), and 14 nonstented patients were maintained on oral diets alone. Stent patients showed a lower rate of interruption of chemoradiotherapy (8% vs. 29% vs. 47%, P = .011). The stent group also demonstrated greater mean improvement in albumin levels (0.14 g/dL vs. −0.39 g/dL vs. −0.45 g/dL, P < .001) and less percentage body weight loss (1.5% vs. 4.2% vs. 5.5%, P < .001). Nasogastric tubes were used for additional nutritional supplementation during the last week of therapy for two stent patients. The rate of stent migration was 24%. Overall, 31% of patients did not go on to resection because of progression to metastatic disease. The rate of major operative complication was 20% vs. 47% vs. 43% among stent, feeding tube, and oral nutrition patients respectively (P = .130).

Conclusions

Esophageal stenting in the neoadjuvant setting offers improved results compared with feeding tubes both in maintaining preoperative nutrition and in tolerance of neoadjuvant chemoradiotherapy. Future protocols of patients treated with multimodal therapy for cancer of the esophagus should investigate the potential therapeutic benefit of using removable silicone esophageal stents as an alternative to feeding tubes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. editors. SEER cancer Statistics review, 1975–2005. Bethesda, MD.: National Cancer Institute. http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER website, 2008.

  2. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O’Byrne K, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2007;245:707–16.

    Article  PubMed  Google Scholar 

  3. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993;11:1118–23.

    CAS  PubMed  Google Scholar 

  4. Larrea J, Vega S, Martinez T, Torrent JM, Vega V, Nunez V. The nutritional status and immunological situation of cancer patients. Nutr Hosp. 1992;7:178–84.

    CAS  PubMed  Google Scholar 

  5. Han-Geurts IJ, Hop WC, Tran TC, Tilanus HW. Nutritional status as a risk factor in esophageal surgery. Dig Surg. 2006;23:159–63.

    Article  CAS  PubMed  Google Scholar 

  6. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623–7.

    Article  CAS  PubMed  Google Scholar 

  7. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, et al. Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol. 2007;30:507–13.

    Article  CAS  PubMed  Google Scholar 

  8. Kassam Z, Wong RK, Ringash J, Ung Y, Kamra J, DeBoer G, et al. A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 2008;20:53–60.

    CAS  Google Scholar 

  9. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327–38.

    Article  CAS  PubMed  Google Scholar 

  10. Windsor A, Braga M, Martindale R, Buenos R, Tepaske R, Kraehenbuehl L, et al. Fit for surgery: an expert panel review on optmising patients prior to surgery, with a particular focus on nutrition. Surgeon. 2004;2:315–9.

    Article  CAS  PubMed  Google Scholar 

  11. O’Gorman RB, Feliciano DV, Matthews KS, Matthews R, Bitondo CG, Mattox KL, et al. Correlation of immunologic and nutritional status with infectious complications after major abdominal trauma. Surgery. 1986;99:549–56.

    PubMed  Google Scholar 

  12. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg. 1999;134:36–42.

    Article  CAS  PubMed  Google Scholar 

  13. Reynolds JV, Ravi N, Hollywood D, Kennedy MJ, Rowley S, Ryan A, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2006;132:549–55.

    Article  PubMed  Google Scholar 

  14. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–43.

    Article  PubMed  Google Scholar 

  15. Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Di C, V. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med. 2001;29:242–8.

    Article  CAS  PubMed  Google Scholar 

  16. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999;229:467–77.

    Article  CAS  PubMed  Google Scholar 

  17. Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg. 1996;224:531–40.

    Article  CAS  PubMed  Google Scholar 

  18. Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg. 1992;216:172–83.

    Article  CAS  PubMed  Google Scholar 

  19. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991;325:525–32.

    Article  Google Scholar 

  20. Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001;358:1487–92.

    Article  CAS  PubMed  Google Scholar 

  21. Jenkinson AD, Lim J, Agrawal N, Menzies D. Laparoscopic feeding jejunostomy in esophagogastric cancer. Surg Endosc. 2007;21:299–302.

    Article  CAS  PubMed  Google Scholar 

  22. Margolis M, Alexander P, Trachiotis GD, Gharagozloo F, Lipman T. Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg. 2003;76:1694–7.

    Article  PubMed  Google Scholar 

  23. Ohnmacht GA, Allen MS, Cassivi SD, Deschamps C, Nichols FC, III, Pairolero PC. Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus. 2006;19:311–2.

    Article  CAS  PubMed  Google Scholar 

  24. Martin R, Duvall R, Ellis S, Scoggins CR. The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care. Surg Endosc. 2009;23:615–21.

    Article  PubMed  Google Scholar 

  25. Costamagna G, Shah SK, Tringali A, Mutignani M, Perri V, Riccioni ME. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc. 2003;17:891–5.

    Article  CAS  PubMed  Google Scholar 

  26. Holm AN, de la Mora Levy JG, Gostout CJ, Topazian MD, Baron TH. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc. 2008;67:20–5.

    Article  PubMed  Google Scholar 

  27. Karbowski M, Schembre D, Kozarek R, Ayub K, Low D. Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endosc. 2008;22:1326–33.

    Article  CAS  PubMed  Google Scholar 

  28. Thompson AM, Rapson T, Gilbert FJ, Park KG. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc. 2004;18:1257–62.

    Article  CAS  PubMed  Google Scholar 

  29. Ponsky JL, Gauderer MW. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc. 1981;27:9–11.

    Article  CAS  PubMed  Google Scholar 

  30. Siddiqui AA, Loren D, Dudnick R, Kowalski T. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci. 2007;52:823–9.

    Article  CAS  PubMed  Google Scholar 

  31. Ott C, Ratiu N, Endlicher E, Rath HC, Gelbmann CM, Scholmerich J, et al. Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes. Surg Endosc. 2007;21:889–96.

    Article  CAS  PubMed  Google Scholar 

  32. Conigliaro R, Battaglia G, Repici A, De Pretis G, Ghezzo L, Bittinger M, et al. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol. 2007;19:195–203.

    Article  PubMed  Google Scholar 

  33. van ME, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008;71:160–6.

    Google Scholar 

  34. Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, et al. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg. 2008;85:1930–6.

    Article  PubMed  Google Scholar 

  35. Bozzetti F, Cozzaglio L, Gavazzi C, Bidoli P, Bonfanti G, Montalto F, et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori. 1998;84:681–6.

    CAS  PubMed  Google Scholar 

  36. Koea JB, Shaw JH. The effect of tumor bulk on the metabolic response to cancer. Ann Surg. 1992;215:282–8.

    Article  CAS  PubMed  Google Scholar 

  37. Saito T, Kuwahara A, Shigemitsu Y, Kinoshita T, Shimoda K, Miyahara M, et al. Factors related to malnutrition in patients with esophageal cancer. Nutrition. 1991;7:117–21.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Martin MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bower, M., Jones, W., Vessels, B. et al. Nutritional Support with Endoluminal Stenting During Neoadjuvant Therapy for Esophageal Malignancy. Ann Surg Oncol 16, 3161–3168 (2009). https://doi.org/10.1245/s10434-009-0630-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0630-2

Keywords

Navigation